BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16361802)

  • 21. Comparison of postoperative chylothorax in infants and children with trisomy 21 and without dysmorphic syndrome: Is there a difference in clinical outcome?
    Buchwald MA; Laasner U; Balmer C; Cannizzaro V; Latal B; Bernet V
    J Pediatr Surg; 2019 Jul; 54(7):1298-1302. PubMed ID: 30057209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Octreotide therapy in two children with intractable postoperative chylothorax.
    Hung WP; Wang JN; Chang HK; Wu JM
    Int J Cardiol; 2011 Feb; 146(3):e63-5. PubMed ID: 19193452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative chylothorax: differences between patients who received median sternotomy or lateral thoracotomy for congenital heart disease.
    Wu JM; Yao CT; Kan CD; Yeh CN; Yang YR; Wang JN
    J Card Surg; 2006; 21(3):249-53. PubMed ID: 16684052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Octreotide and low-fat breast milk in postoperative chylothorax.
    Hamdan MA; Gaeta ML
    Ann Thorac Surg; 2004 Jun; 77(6):2215-7. PubMed ID: 15172311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of octreotide acetate on intractable chylothorax after surgery for congenital heart diseases].
    Kaneko M; Hiramatsu T; Nishimura Y; Iwahashi M; Komori S; Shibata M; Yuzaki M; Okamura Y; Suzuki H; Takeuchi T; Shibuta S
    Kyobu Geka; 2006 Jul; 59(7):561-4. PubMed ID: 16856532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative Chylothorax in Neonates and Infants after Congenital Heart Disease Surgery-Current Aspects in Diagnosis and Treatment.
    Samanidis G; Kourelis G; Bounta S; Kanakis M
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Balloon Angioplasty for the Treatment of Left Innominate Vein Obstruction Related Chylothorax after Congenital Heart Surgery.
    Law MA; McMahon WS; Hock KM; Zaccagni HJ; Borasino S; Alten JA
    Congenit Heart Dis; 2015; 10(4):E155-63. PubMed ID: 25600286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of persistent chylothorax after Norwood procedure with somatostatin.
    Pettitt TW; Caspi J; Borne A
    Ann Thorac Surg; 2002 Mar; 73(3):977-9. PubMed ID: 11899219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chylothorax after surgery for congenital heart disease.
    Zuluaga MT
    Curr Opin Pediatr; 2012 Jun; 24(3):291-4. PubMed ID: 22498675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chylothorax following paediatric cardiac surgery: a case-control study.
    Day TG; Zannino D; Golshevsky D; d'Udekem Y; Brizard C; Cheung MMH
    Cardiol Young; 2018 Feb; 28(2):222-228. PubMed ID: 28835310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How efficacious are Octreotide and Somatostatin in the management of chylothorax in congenital cardiac surgical patients?
    Madhavan S; Nakao M
    Interact Cardiovasc Thorac Surg; 2021 Oct; 33(5):773-778. PubMed ID: 34000045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Octreotide treatment of post surgical chylothorax].
    Aleo Luján E; Urán Moreno MM; Brandstrup Azuero KB; López-Herce Cid J; Zunzunegui Martínez JL
    An Pediatr (Barc); 2003 Apr; 58(4):390-2. PubMed ID: 12681190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Octreotide for treatment of postoperative chylothorax.
    Cheung Y; Leung MP; Yip M
    J Pediatr; 2001 Jul; 139(1):157-9. PubMed ID: 11445812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chylothorax in a premature infant using somatostatin.
    Goto M; Kawamata K; Kitano M; Watanabe K; Chiba Y
    J Perinatol; 2003 Oct; 23(7):563-4. PubMed ID: 14566354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective.
    Aljazairi AS; Bhuiyan TA; Alwadai AH; Almehizia RA
    Asian Cardiovasc Thorac Ann; 2017 Jan; 25(1):6-12. PubMed ID: 27920229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of refractory chylothorax after pediatric cardiovascular surgery.
    Matsuo S; Takahashi G; Konishi A; Sai S
    Pediatr Cardiol; 2013 Jun; 34(5):1094-9. PubMed ID: 23229292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery.
    Schroth M; Meißner U; Cesnjevar R; Weyand M; Singer H; Rascher W; Klinge J
    Pediatr Cardiol; 2006; 27(1):56-60. PubMed ID: 16082570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia.
    Goyal A; Smith NP; Jesudason EC; Kerr S; Losty PD
    J Pediatr Surg; 2003 Aug; 38(8):E19-20. PubMed ID: 12891519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide in the management of postoperative chylothorax.
    Rosti L; De Battisti F; Butera G; Cirri S; Chessa M; Delogu A; Drago M; Giamberti A; Pomè G; Carminati M; Frigiola A
    Pediatr Cardiol; 2005; 26(4):440-3. PubMed ID: 16374694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.